XBiotech XBIT
NASDAQ XBIT
$2.19 -0.01 (-0.45%)
At close: Oct 2, 2026 · 4:00 PM EDT

XBiotech (XBIT) Other Accumulated Expenses (2014 - 2025)

Updated

XBiotech's Other Accumulated Expenses was $39,000 in Q4 2025, down 90.3% from $404,000 a year earlier.

Analysis

XBiotech (XBIT) Other Accumulated Expenses (2014 - 2025) Analysis & Trends

From Q4 2014 onward, XBiotech has reported Other Accumulated Expenses for 12 quarters.

  • Other Accumulated Expenses shows a five-year compound annual growth rate of -30.3% (FY2020 to FY2025).
  • In earlier years, Other Accumulated Expenses was $404,000 in FY2024 (+562.3%), $61,000 in FY2023 (-11.6%), $69,000 in FY2022 (-38.9%) and $113,000 in FY2021 (-52.3%).
  • The Q4 2025 figure marks the lowest quarterly Other Accumulated Expenses since Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 XBiotech 66.77 Mn 66.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 39,000.00
Dec 31, 2024 404,000.00
Dec 31, 2023 61,000.00
Dec 31, 2022 69,000.00
Dec 31, 2021 113,000.00
Dec 31, 2020 237,000.00
Dec 31, 2019 195,000.00
Dec 31, 2018 36,000.00
Dec 31, 2017 30,000.00
Dec 31, 2016 101,000.00
Dec 31, 2015 329,000.00
Dec 31, 2014 164,000.00
API Access

XBiotech Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=XBIT&period=max&api_key=YOUR_API_KEY